(TM) Toyota Motor - Ratings and Ratios
Cars, Trucks, Minivans, SUVs, Hybrids
Dividends
| Dividend Yield | 3.28% |
| Yield on Cost 5y | 5.39% |
| Yield CAGR 5y | 6.54% |
| Payout Consistency | 94.5% |
| Payout Ratio | 9.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.8% |
| Value at Risk 5%th | 44.5% |
| Relative Tail Risk | -2.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.59 |
| Alpha | 6.15 |
| CAGR/Max DD | 0.44 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.449 |
| Beta | 0.895 |
| Beta Downside | 0.830 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.92% |
| Mean DD | 14.48% |
| Median DD | 14.37% |
Description: TM Toyota Motor December 01, 2025
Toyota Motor Corporation (NYSE: TM) designs, manufactures, assembles, and sells a full spectrum of passenger, commercial, and specialty vehicles-including subcompact cars, SUVs, pickups, minivans, trucks, and buses-across every major global region. Its operations are organized into three segments: Automotive, Financial Services, and All Other.
The company markets vehicles under the Toyota and Lexus brands and is actively expanding its battery-electric vehicle (BEV) lineup and battery production capacity, while maintaining leadership in hybrid technology.
Beyond vehicle sales, Toyota provides a suite of financial services-retail and wholesale financing, leasing, insurance, and credit cards-and runs ancillary businesses such as the GAZOO.com automotive portal and select telecommunications ventures.
Key recent metrics: FY 2023 revenue reached roughly $275 billion, with net profit of about $21 billion; BEV deliveries grew ~70 % year-over-year, driven by the launch of the bZ Series; and R&D spending stayed near $10 billion, reflecting a continued focus on electrification and autonomous-driving technologies. Macro drivers include the ongoing global chip shortage, which pressures inventory, and the yen-dollar exchange rate, which can swing earnings by several percentage points.
For a deeper, data-rich dive into Toyota’s valuation dynamics, you might find ValueRay’s analyst tools useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (4631.40b TTM) > 0 and > 6% of Revenue (6% = 2963.10b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 1.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.02% (prev 13.78%; Δ 2.24pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 4824.37b > Net Income 4631.40b (YES >=105%, WARN >=100%) |
| Net Debt (31751.35b) to EBITDA (8470.75b) ratio: 3.75 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.30b) change vs 12m ago -1.96% (target <= -2.0% for YES) |
| Gross Margin 17.97% (prev 21.13%; Δ -3.16pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.89% (prev 52.03%; Δ 0.86pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 38.49 (EBITDA TTM 8470.75b / Interest Expense TTM 161.49b) >= 6 (WARN >= 3) |
Altman Z'' 2.95
| (A) 0.08 = (Total Current Assets 38942.72b - Total Current Liabilities 31031.19b) / Total Assets 97574.88b |
| (B) 0.38 = Retained Earnings (Balance) 37061.82b / Total Assets 97574.88b |
| (C) 0.07 = EBIT TTM 6216.07b / Avg Total Assets 93372.09b |
| (D) 0.70 = Book Value of Equity 41454.10b / Total Liabilities 59117.92b |
| Total Rating: 2.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.37
| 1. Piotroski 4.0pt |
| 2. FCF Yield 0.23% |
| 3. FCF Margin 0.30% |
| 4. Debt/Equity 1.06 |
| 5. Debt/Ebitda 3.75 |
| 6. ROIC - WACC (= 1.86)% |
| 7. RoE 12.74% |
| 8. Rev. Trend 93.62% |
| 9. EPS Trend 45.22% |
What is the price of TM shares?
Over the past week, the price has changed by -1.63%, over one month by -4.24%, over three months by +3.35% and over the past year by +16.03%.
Is TM a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 230.6 | 17.1% |
| Analysts Target Price | 230.6 | 17.1% |
| ValueRay Target Price | 224.4 | 13.9% |
TM Fundamental Data Overview November 25, 2025
P/E Trailing = 8.7948
P/E Forward = 13.2979
P/S = 0.0052
P/B = 1.0788
P/EG = 1.5387
Beta = 0.226
Revenue TTM = 49385.01b JPY
EBIT TTM = 6216.07b JPY
EBITDA TTM = 8470.75b JPY
Long Term Debt = 23628.74b JPY (from longTermDebt, last quarter)
Short Term Debt = 16235.53b JPY (from shortTermDebt, last quarter)
Debt = 39864.28b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 31751.35b JPY (from netDebt column, last quarter)
Enterprise Value = 63013.20b JPY (40067.20b + Debt 39864.28b - CCE 16918.27b)
Interest Coverage Ratio = 38.49 (Ebit TTM 6216.07b / Interest Expense TTM 161.49b)
FCF Yield = 0.23% (FCF TTM 147.79b / Enterprise Value 63013.20b)
FCF Margin = 0.30% (FCF TTM 147.79b / Revenue TTM 49385.01b)
Net Margin = 9.38% (Net Income TTM 4631.40b / Revenue TTM 49385.01b)
Gross Margin = 17.97% ((Revenue TTM 49385.01b - Cost of Revenue TTM 40509.25b) / Revenue TTM)
Gross Margin QoQ = 15.91% (prev 17.92%)
Tobins Q-Ratio = 0.65 (Enterprise Value 63013.20b / Total Assets 97574.88b)
Interest Expense / Debt = 0.05% (Interest Expense 18.80b / Debt 39864.28b)
Taxrate = 20.64% (253.03b / 1225.98b)
NOPAT = 4933.11b (EBIT 6216.07b * (1 - 20.64%))
Current Ratio = 1.25 (Total Current Assets 38942.72b / Total Current Liabilities 31031.19b)
Debt / Equity = 1.06 (Debt 39864.28b / totalStockholderEquity, last quarter 37492.12b)
Debt / EBITDA = 3.75 (Net Debt 31751.35b / EBITDA 8470.75b)
Debt / FCF = 214.8 (Net Debt 31751.35b / FCF TTM 147.79b)
Total Stockholder Equity = 36341.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.75% (Net Income 4631.40b / Total Assets 97574.88b)
RoE = 12.74% (Net Income TTM 4631.40b / Total Stockholder Equity 36341.85b)
RoCE = 10.37% (EBIT 6216.07b / Capital Employed (Equity 36341.85b + L.T.Debt 23628.74b))
RoIC = 6.54% (NOPAT 4933.11b / Invested Capital 75378.67b)
WACC = 4.69% (E(40067.20b)/V(79931.47b) * Re(9.31%) + D(39864.28b)/V(79931.47b) * Rd(0.05%) * (1-Tc(0.21)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.72%
[DCF Debug] Terminal Value 77.44% ; FCFE base≈147.79b ; Y1≈182.32b ; Y5≈311.06b
Fair Price DCF = 3224 (DCF Value 4201.51b / Shares Outstanding 1.30b; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 45.22 | EPS CAGR: -1.60% | SUE: -0.04 | # QB: 0
Revenue Correlation: 93.62 | Revenue CAGR: 13.16% | SUE: 0.01 | # QB: 0
EPS current Year (2026-03-31): EPS=16.63 | Chg30d=-1.114 | Revisions Net=+1 | Growth EPS=-32.9% | Growth Revenue=+174.0%
EPS next Year (2027-03-31): EPS=20.39 | Chg30d=-2.580 | Revisions Net=+1 | Growth EPS=+22.6% | Growth Revenue=+3.4%
Additional Sources for TM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle